herpetic keratitis
Recently Published Documents


TOTAL DOCUMENTS

360
(FIVE YEARS 34)

H-INDEX

29
(FIVE YEARS 1)

Cureus ◽  
2022 ◽  
Author(s):  
Hassan Alkwikbi ◽  
Mohammed Alenazi ◽  
Wafi Alanazi ◽  
Shahad Alruwaili

Author(s):  
Mi Yeon Song ◽  
Kyung Min Koh ◽  
Kyu Yeon Hwang ◽  
Young A Kwon ◽  
Kook Young Kim
Keyword(s):  

Author(s):  
Min Seung Kang ◽  
Sang Min Lee ◽  
Sung Il Kim ◽  
Ji Eun Lee

Vaccines ◽  
2021 ◽  
Vol 9 (12) ◽  
pp. 1394
Author(s):  
Saiqun Li ◽  
Xiuhua Jia ◽  
Fei Yu ◽  
Qian Wang ◽  
Tingting Zhang ◽  
...  

The global Coronavirus Disease 2019 (COVID-19) pandemic has accelerated vaccine development at an unprecedented rate. A large population of people have received COVID-19 vaccines, while the vaccine safety data are limited. Here, we reported two cases of herpetic keratitis that occurred soon after receiving the inactivated COVID-19 vaccines. Case 1 was a 60-year-old woman who underwent penetrating keratoplasty (PKP) one year ago for corneal scarring caused by herpes simplex keratitis (HSK), and case 2 was a 51-year-old man with an unremarkable medical history. Both patients developed herpetic keratitis (HSK and varicella-zoster virus corneal endotheliitis, respectively) soon after receiving the inactivated COVID-19 vaccines (Sinovac). Herpetic keratitis was treated successfully with topical or plus oral antiviral ganciclovir. The short latency time in these two cases suggested that an inactivated COVID-19 vaccine may have a risk of triggering ocular herpes virus reactivation. Both clinicians and patients should be aware of this phenomenon. However, a causal relationship awaits confirmation.


2021 ◽  
Vol 10 (12) ◽  
pp. 2684
Author(s):  
Ewa Wróblewska-Czajka ◽  
Anna Nowińska ◽  
Dariusz Dobrowolski ◽  
Dominika Szkodny ◽  
Edward Wylęgała

Background: The aim of this study was to perform a retrospective analysis of patients who underwent cross-linking for keratoconus, in the Department of Ophthalmology of the Medical University of Silesia in Katowice, between 2011 and 2020, regarding the occurrence of herpetic keratitis after the procedure. Methods: We analyzed the medical history of 543 patients who underwent cross-linking surgery. Results: In the analyzed group, there were nine cases of herpetic keratitis (six men and three women), aged from 16 to 40 years (mean 26.2 years). The mean follow-up period was 49.3 months (16–82 months). The average time from surgery to the manifestation of the first symptoms of keratitis was 4.3 days (2–6 days). In two cases, iritis was observed, and in one of them, iritis was the first symptom. After systemic and topical administration of acyclovir, ulceration healed in all patients. Corneal healing time ranged from 10 days to 3 weeks (average 13.7 days). In one patient, a recurrence of the inflammation was observed after 8 months. Conclusion: Patients should be carefully observed in the early post-CXL period. Herpetic keratitis could be induced by CXL even in patients with no history of herpetic disease.


2021 ◽  
Author(s):  
Anna Nowińska

The chapter is focused on one of the major cause of keratitis - Herpetic keratitis, its epidemiology, natural course, clinical forms, prognosis, diagnosis and treatment. The estimated global incidence of HSV keratitis is roughly 1,5 million, including 40,000 new cases of each year. Patients are usually affected in the early decades of live, therefore the disease has a severe impact on quality of life and quality of vision in young, productive adults. The author describes the detailed corneal characteristics, provides slit lamp photographs, optical coherence tomography scans and confocal microscopy results of different forms of the HSV keratitis: epithelial, stromal, necrotizing and endothelial. The chapter also discusses recent methods of diagnosis based on PCR testing as well as established and future methods of treatment based on the latest research results.


Author(s):  
Ming-Chih Ho ◽  
Eugene Yu-Chuan Kang ◽  
Lung-Kun Yeh ◽  
David H. K. Ma ◽  
Hsin-Chiung Lin ◽  
...  

Abstract Background Burkholderia cepacia, an opportunistic pathogen mainly affecting patients with cystic fibrosis or immunocompromised, has rarely been documented as a cause of corneal infection. The clinical and microbiological profiles of B. cepacia keratitis are reported herein. Methods We retrospectively reviewed the medical record of 17 patients with culture-proven B. cepacia keratitis, treated between 2000 and 2019 at Chang Gung Memorial Hospital, Taiwan. Our data included predisposing factors, clinical presentations, treatments, and visual outcomes of B. cepacia keratitis as well as the drug susceptibility of the causative agent. Results The most common predisposing factor for B. cepacia keratitis was preexisting ocular disease (seven, 41.2%), particularly herpetic keratitis (five). Polymicrobial infection was detected in seven (41.2%) eyes. All B. cepacia isolates were susceptible to ceftazidime. Main medical treatments included levofloxacin or ceftazidime. Surgical treatment was required in five (29.4%) patients. Only four (23.5%) patients exhibited final visual acuity better than 20/200. Conclusions B. cepacia keratitis primarily affects patients with preexisting ocular disease, particularly herpetic keratitis, and responds well to ceftazidime or fluoroquinolones. However, the visual outcomes are generally poor.


Author(s):  
Harpal S. Sandhu ◽  
Danielle Trief
Keyword(s):  

2021 ◽  
Vol 99 (S265) ◽  
Author(s):  
Emilie Courrier ◽  
Corantin Maurin ◽  
Thomas Bourlet ◽  
Pascal Herbepin ◽  
Verhoeven Paul ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document